Durgam S, et al. - The goal of this paper was to determine the efficacy of cariprazine in the treatment of bipolar I disorder and schizophrenia. The post hoc analyses illustrated that more cariprazine-than placebo-treated patients with bipolar mania or schizophrenia exhibited statistically prominent and clinically significant Clinical Global Impressions-Severity (CGI-S) improvement.